Biodexa Pharmaceuticals (LON:MTPH) Share Price Passes Above 50 Day Moving Average of $18.00

Biodexa Pharmaceuticals Plc (LON:MTPH)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 18 ($0.24) and traded as high as GBX 20 ($0.26). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.24), with a volume of 73,672 shares.

Biodexa Pharmaceuticals Price Performance

The stock has a market capitalization of £31.20 million, a price-to-earnings ratio of -21.95 and a beta of 1.22. The company has a quick ratio of 5.28, a current ratio of 5.28 and a debt-to-equity ratio of 9.52. The business’s 50-day moving average is GBX 18 and its two-hundred day moving average is GBX 18.

Biodexa Pharmaceuticals Company Profile

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.